DK1392830T3 - Interleukin-18 mutanter, deres fremstilling og anvendelse - Google Patents

Interleukin-18 mutanter, deres fremstilling og anvendelse

Info

Publication number
DK1392830T3
DK1392830T3 DK02758668T DK02758668T DK1392830T3 DK 1392830 T3 DK1392830 T3 DK 1392830T3 DK 02758668 T DK02758668 T DK 02758668T DK 02758668 T DK02758668 T DK 02758668T DK 1392830 T3 DK1392830 T3 DK 1392830T3
Authority
DK
Denmark
Prior art keywords
mutants
interleukin
preparation
molecule
wild type
Prior art date
Application number
DK02758668T
Other languages
Danish (da)
English (en)
Inventor
Charles Dinarello
Soo-Hyun Kim
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Application granted granted Critical
Publication of DK1392830T3 publication Critical patent/DK1392830T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK02758668T 2001-03-08 2002-03-08 Interleukin-18 mutanter, deres fremstilling og anvendelse DK1392830T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27432701P 2001-03-08 2001-03-08

Publications (1)

Publication Number Publication Date
DK1392830T3 true DK1392830T3 (da) 2006-05-08

Family

ID=23047735

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02758668T DK1392830T3 (da) 2001-03-08 2002-03-08 Interleukin-18 mutanter, deres fremstilling og anvendelse

Country Status (19)

Country Link
US (2) US7524488B2 (es)
EP (1) EP1392830B1 (es)
JP (1) JP2004530432A (es)
KR (1) KR100862136B1 (es)
CN (1) CN100503829C (es)
AT (1) ATE315647T1 (es)
AU (1) AU2002324249B2 (es)
BR (1) BRPI0207933B8 (es)
CA (1) CA2438851C (es)
DE (1) DE60208692T2 (es)
DK (1) DK1392830T3 (es)
EA (1) EA005769B1 (es)
ES (1) ES2251610T3 (es)
HK (1) HK1084151A1 (es)
IL (2) IL157800A0 (es)
MX (1) MXPA03008110A (es)
SI (1) SI1392830T1 (es)
UA (1) UA79235C2 (es)
WO (1) WO2002101049A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004031341D1 (de) 2003-07-21 2011-03-24 Transgene Sa Multifunktionelle cytokine
WO2005014642A2 (en) * 2003-07-21 2005-02-17 Transgene S.A. Novel multifunctional cytokines
PT1689777E (pt) * 2003-11-05 2007-05-31 Ares Trading Sa Processo para a purificação da proteína de ligação a il-18
US7557084B2 (en) * 2004-03-31 2009-07-07 Regeneron Pharmaceuticals, Inc. IL-18 specific polypeptides and therapeutic uses thereof
CA2609060C (en) 2005-06-03 2014-07-15 Urs Weber Production of recombinant il-18 binding protein
PT1891088E (pt) 2005-06-10 2011-12-19 Ares Trading Sa Processo para a purificação da proteína de ligação il-18
CN101177454B (zh) * 2007-05-09 2010-09-22 郑骏年 Il-18突变体多肽及制备及用途
WO2012078936A2 (en) * 2010-12-10 2012-06-14 Glaxosmithkline Llc Methods to produce a purified peptide chain fraction
IL305370A (en) * 2017-09-06 2023-10-01 Univ Yale Variants of interleukin-18 and methods of use
US12029778B2 (en) 2019-05-13 2024-07-09 Yale University Interleukin-18 mimics and methods of use
JP2021170968A (ja) * 2020-04-22 2021-11-01 国立大学法人 長崎大学 マウスil−18の製造方法及びそのための組換えdna
CA3189327A1 (en) * 2020-08-19 2022-02-24 Vijaya Raghavan PATTABIRAMAN Modified il-18 polypeptides and uses thereof
WO2022094473A1 (en) 2020-11-02 2022-05-05 Simcha IL-18, Inc. Interleukin-18 variants and methods of use
WO2022172944A1 (ja) * 2021-02-10 2022-08-18 国立大学法人 長崎大学 新規ヒトインターロイキン-18変異体及びその用途
WO2023010021A1 (en) 2021-07-27 2023-02-02 Xencor, Inc. Il-18-fc fusion proteins
JP2023024168A (ja) 2021-08-06 2023-02-16 国立大学法人 長崎大学 がんの治療剤
WO2023056193A2 (en) * 2021-09-29 2023-04-06 Chimera Bioengineering, Inc. Il-18 variants and uses thereof
WO2023118497A1 (en) * 2021-12-22 2023-06-29 Pieris Pharmaceuticals Gmbh Novel il-18 variants
US20230355795A1 (en) * 2022-02-23 2023-11-09 Bright Peak Therapeutics Ag Immune antigen specific il-18 immunocytokines and uses thereof
WO2023161853A1 (en) 2022-02-23 2023-08-31 Bright Peak Therapeutics Ag Activatable il-18 polypeptides
AU2023224445A1 (en) * 2022-02-23 2024-08-29 Bright Peak Therapeutics Ag Modified il-18 polypeptides
WO2024044780A1 (en) * 2022-08-26 2024-02-29 Sutro Biopharma, Inc. Interleukin-18 variants and uses thereof
WO2024102693A2 (en) 2022-11-07 2024-05-16 Xencor, Inc. Il-18-fc fusion proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4024366B2 (ja) * 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド
TWI227136B (en) * 1998-05-21 2005-02-01 Smithkline Beecham Corp Novel pharmaceutical composition for the prevention and/or treatment of cancer
IL129427A0 (en) 1999-04-13 2000-02-17 Yeda Res & Dev Preparation of biologically active molecules

Also Published As

Publication number Publication date
BR0207933A (pt) 2004-03-02
ATE315647T1 (de) 2006-02-15
WO2002101049A3 (en) 2003-12-18
IL157800A (en) 2009-08-03
CN100503829C (zh) 2009-06-24
JP2004530432A (ja) 2004-10-07
AU2002324249B2 (en) 2007-04-05
SI1392830T1 (sl) 2006-06-30
EA200300987A1 (ru) 2004-02-26
KR100862136B1 (ko) 2008-10-09
US20090286855A1 (en) 2009-11-19
UA79235C2 (en) 2007-06-11
DE60208692D1 (de) 2006-04-06
HK1084151A1 (en) 2006-07-21
DE60208692T2 (de) 2006-07-13
WO2002101049A2 (en) 2002-12-19
MXPA03008110A (es) 2003-12-12
CN1764723A (zh) 2006-04-26
US20020169291A1 (en) 2002-11-14
CA2438851A1 (en) 2002-12-19
ES2251610T3 (es) 2006-05-01
EP1392830A2 (en) 2004-03-03
CA2438851C (en) 2011-07-26
US7875709B2 (en) 2011-01-25
BRPI0207933B1 (pt) 2020-11-24
EA005769B1 (ru) 2005-06-30
BRPI0207933B8 (pt) 2021-05-25
IL157800A0 (en) 2004-03-28
US7524488B2 (en) 2009-04-28
KR20030088448A (ko) 2003-11-19
EP1392830B1 (en) 2006-01-11

Similar Documents

Publication Publication Date Title
DK1392830T3 (da) Interleukin-18 mutanter, deres fremstilling og anvendelse
ATE449840T1 (de) Alpha-amylasevariante mit veränderten eigenschaften
ATE347057T1 (de) Federelement
DK1562968T3 (da) Anti-il-6-antistoffer, sammensætninger, fremgangsmåder og anvendelser
MA30153B1 (fr) Anticorps anti-ox40l et methodes correspondantes
MXPA03010909A (es) Derivados de epotilona.
DE60140214D1 (de) Schraube zur befestigung der wirbelsäule
MXPA04012614A (es) Xilanasas, acidos nucleicos que las codifican, y metodos para hacerlas y usarlas.
DE60206272D1 (de) Chelatorkonjugate mit verbesserten eigenschaften
WO2002053104A3 (en) Use of catecholamine reuptake inhibitors to enhance memory
IL175646A0 (en) Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
WO2003029289A3 (en) Fragements of heat shock proteins and their use
DK1339853T3 (da) Isolerede luciferaser og deres anvendelse
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
DE60330116D1 (de) Aus fisch gewonnene peptide und nukleinsäuren der cathelicidin familie und deren verwendung
CY1109904T1 (el) Προαγωγεας της il-18bp, η παρασκευη και χρηση του
AU2003259750A8 (en) Methods and compositions for targeting secretory lysosomes
NO20042768L (no) IFNAR2 mutanter, deres fremstilling og anvendelse
ES2192034T3 (es) Feniluracilos substituidos con efecto herbicida.
WO2003057711A3 (en) Isolated cytokine receptor licr-2
WO2002063013A3 (en) Human acid phosphatase gene
TW200519206A (en) Methods for producing novel medaka and novel medaka
BR8201310U (pt) Estofados de estrutura metálica
SE0100412D0 (sv) Novel human poly(A) polymerase
BR8101216Y1 (pt) conjunto de cadeira e prancheta com deslocamento regulÁvel.